Management of psychiatric disease in hepatitis C treatment candidates

Current Hepatitis Reports

Volumn 9, Issue 2, 2010, Pages 113-118

  Lotrich, Francis ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Depression; Interferon; Prevention; Screening; Treatment

Indexed keywords

ALPHA INTERFERON; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; HYDROXYZINE; METHYLPHENIDATE; MIRTAZAPINE; MODAFINIL; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRAZODONE;

ANGER; ANXIETY DISORDER; CLINICAL TRIAL; COMORBIDITY; DAYTIME SOMNOLENCE; DEPRESSION; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; HEPATITIS C; HUMAN; INSOMNIA; INTEGRATED HEALTH CARE SYSTEM; IRRITABILITY; KINESIOTHERAPY; LIVER TOXICITY; MAJOR DEPRESSION; MANIA; MENTAL DISEASE; PATIENT ASSESSMENT; PATIENT MONITORING; PREDICTION; PRURITUS; PSYCHOSIS; REVIEW; SIDE EFFECT; SLEEP DISORDER; TREATMENT OUTCOME;

EID: 77955982189     PISSN: 15403416     EISSN: 15410706     Source Type: Journal    
DOI: 10.1007/s11901-010-0035-5     Document Type: Review

References (40)

1. CL Raison AS Borisov M Majer, et al. 2009 Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression Biol Psychiatry 65 296 303 10.1016/j.biopsych.2008.08.010 1:CAS:528:DC%2BD1MXhtFeksrY%3D 18801471 Patients receiving IFN-α provided cerebrospinal fluid that demonstrated the presence of IFN-α, along with IL-6 and serotonin metabolites, some of which correlated with worsened depression symptoms
2. L Capuron G Pagnoni M Demetrashvili, et al. 2005 Anterior cingulate activation and error processing during interferon-alpha treatment Biol Psychiatry 58 190 196 10.1016/j.biopsych.2005.03.033 1:CAS:528: DC%2BD2MXntVGhtLo%3D 16084839
3. H Shuto Y Kataoka T Horikawa, et al. 1997 Repeated interferon-a administration inhibits dopaminergic neural activity in the mouse brain Brain Res 747 348 351 10.1016/S0006-8993(96)01371-6 1:CAS:528:DyaK2sXnsFymtA%3D%3D 9046014
4. L Castera A Constant C Henry P Couzigou 2005 Psychiatric disorders during treatment of chronic hepatitis C Gastroenterol Clin Biol 29 123 133 15795658
5. SH Dinwiddie L Shicher T Newman 2003 Prevalence of hepatitis C among psychiatric patients in the public sector Am J Psychiatry 160 172 174 10.1176/appi.ajp.160.1.172 12505819
6. SC Batista-Neves LC Quarantini AG de Almeida, et al. 2008 High frequency of unrecognized mental disorders in HCV-infected patients Gen Hosp Psychiatry 30 80 82 10.1016/j.genhosppsych.2007.08.014 18164946
7. EJ Bini N Brau S Currie, et al. 2005 Prospective multicenter study of eligibility for antiviral therapy among 4, 084 US veterans with chronic hepatitis C virus infection Am J Gastroenterol 100 1772 1779 10.1111/j.1572-0241.2005.41860.x 16086714
8. SB Ho H Nguyen LL Tetrick, et al. 2001 Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population Am J Gastroenterol 96 157 164 1:CAS:528:DC%2BD3MXhtFKjsrk%3D 11197246
9. J Goldsmith P Hauser 2003 Psychiatric issues in patients with hepatitis C Psychiatr Ann 33 357 360
10. S Hosoda H Takimura M Shibayama, et al. 2000 Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis Psychiatry Clin Neurosci 54 565 572 10.1046/j.1440-1819.2000.00754.x 1:STN:280:DC%2BD3cvptFemtQ%3D%3D 11043807
11. CL Raison AS Borisov SD Broadwell, et al. 2005 Depression during pegylated interferon-alpha plus ribarin therapy: prevalence and prediction J Clin Psychiatry 66 41 48 10.4088/JCP.v66n0106 1:CAS:528:DC%2BD2MXhsV2htLw%3D 15669887
12. MR Kraus A Schafer K Schottker, et al. 2008 Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomized, double-blind, placebo-controlled study Gut 57 531 536 10.1136/gut.2007.131607 1:CAS:528:DC%2BD1cXltVKntbc%3D 18079286 This randomized, placebo-controlled trial found that most patients with IFN-MDD responded very well to the SSRI, whereas most patients on placebo continued to get worse
13. OC Gleason WR Yates MD Isbell MA Philipsen 2002 An open-label trial of citalopram for major depression in patients with hepatitis C J Clin Psychiatry 63 194 198 1:CAS:528:DC%2BD38XjtFSitL0%3D 11926717
14. OC Gleason WR Yates MA Philipsen, et al. 2004 Plasma levels of citalopram in depressed patients with hepatitis C Psychosomatics 45 29 33 10.1176/appi.psy.45.1.29 1:CAS:528:DC%2BD2cXhsVamtLw%3D 14709758
15. S Sockalingam SE Abbey 2009 Managing depression during hepatitis C treatment Can J Psychiatry 54 614 625 19751550
16. CL Raison M Demetrashvili L Capuron AH Miller 2005 Neuropsychiatric adverse effects of interferon-α: recognition and management CNS Drugs 19 105 123 10.2165/00023210-200519020-00002 1:CAS:528:DC%2BD2MXislCqs7o%3D 15697325
17. GM Asnis R De La Garza 2nd 2006 Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches J Clin Gastroenterol 40 322 335 10.1097/01.mcg.0000210099.36500.fe 1:CAS:528:DC%2BD28Xjs1yrurc%3D 16633105
18. L Capuron JF Gumnick DL Musselman, et al. 2002 Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions Neuropsychopharmacology 26 643 652 10.1016/S0893-133X(01)00407-9 1:CAS:528:DC%2BD38Xitlaqsr8%3D 11927189
19. L Capuron AH Miller 2004 Cytokines and psychopathology: lessons from interferon-α Biol Psychiatry 56 819 824 10.1016/j.biopsych.2004.02.009 1:CAS:528:DC%2BD2cXhtVCktL7N 15576057
20. KA Martin LE Krahn V Balan MJ Rosati 2007 Modafinil's use in combating interferon-induced fatigue Dig Dis Sci 52 893 896 10.1007/s10620-006-9519-0 1:CAS:528:DC%2BD2sXjsVSjt74%3D 17318387
21. AL Schwartz JA Thompson N Masood 2002 Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate Oncol Nurs Forum 29 E85 E90 10.1188/02.ONF.E85-E90 12183762
22. Franzen PL, Buysse DJ, Rabinovitz M, et al.: Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment. J Psychiatr Res 2009 (E-pub ahead of print); doi: 10.1016/j.psychres.2009.02.011.
23. AA Dan C Crone TN Wise, et al. 2007 Anger experiences among hepatitis C patients: relationship to depressive symptoms and health-related quality of life Psychosomatics 48 223 229 10.1176/appi.psy.48.3.223 17478591
24. M Preau F Marcellin B Spire, et al. 2008 Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients J Clin Gastroenterol 42 92 96 10.1097/01.mcg.0000225645. 75651.b8 18097297
25. FE Lotrich M Rabinovitz P Gironda BG Pollock 2007 Depression following pegylated interferon-alpha: characteristics and vulnerability J Psychosomat Res 63 131 135 10.1016/j.jpsychores.2007.05.013
26. P Malek-Ahmadi RC Hilsabeck 2007 Neuropsychiatric complications of interferons: classification, neurochemical bases, and management Ann Clin Psychiatry 19 113 123 10.1080/10401230701333038 17612851 This article provides a good general review for psychiatrists treating patients who are receiving IFN-α
27. DB Greenberg E Jonasch MA Gadd, et al. 2000 Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes Cancer 89 356 362 10.1002/1097-0142(20000715)89:2<356::AID-CNCR21>3.0.CO;2-Z 1:CAS:528:DC%2BD3cXlslaqsb8%3D 10918166
28. CU Onyike JO Bonner CG Lykestsos GJ Treisman 2004 Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin Am J Psychiatry 161 429 435 10.1176/appi.ajp.161.3.429 14992966
29. G Fattovich G Giustina S Favarato A Ruol 1996 A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon J Hepatol 24 38 47 10.1016/S0168-8278(96)80184-X 1:STN:280:DyaK28vjtV2nsw%3D%3D 8834023
30. RG Hoffman MA Cohen CA Alfonso, et al. 2003 Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV Psychosomatics 44 417 440 10.1176/appi.psy.44.5.417 12954918
31. L Capuron A Ravaud R Dantzer 2001 Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha in cancer patients Psychosom Med 63 376 386 1:CAS:528:DC%2BD3MXkt1Crs7c%3D 11382265
32. T Nickel A Sonntag M Backmund T Pollmacher 2005 Depression during therapy with interferon alpha-how long should an antidepressant treatment last? Pharmacopsychiatry 38 102 104 10.1055/s-2005-837813 1:STN:280: DC%2BD2M7mslSgtg%3D%3D 15744637
33. Lotrich FE: Prevention of depression during interferon-alpha treatment. Dialogues Clin Neurosci 2009, 11(4):417-426.
34. BJ Morasco MA Rifai JM Loftis, et al. 2007 A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C [published erratum in J Affect Disord 2009, 113:201] J Affect Disord 103 83 90 10.1016/j.jad.2007.01.007 1:CAS:528:DC%2BD2sXhtFSltr7J 17292481 This double-blind, placebo-controlled trial did not find that the SSRI was better at preventing MDD than placebo. However, post-hoc exploratory analyses indicated that SSRIs were useful in alleviating depression symptoms after they had developed
35. CL Raison BJ Woolwine MF Demetrashvili, et al. 2007 Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C Aliment Pharmacol Ther 25 1163 1174 1:CAS:528:DC%2BD2sXmtlert70%3D 17451562 This double-blind, placebo-controlled trial did not find that the SSRI was better at preventing MDD than placebo. However, post-hoc exploratory analyses indicated a potential prophylactic benefit for the SSRI when used to treat subthreshhold depression
36. FE Lotrich RE Ferrell M Rabinovitz BG Pollock 2009 Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism Biol Psychiatry 65 344 348 10.1016/j.biopsych.2008.08.009 1:CAS:528:DC%2BD1MXhtFeks70%3D 18801474
37. SJ Bull P Huezo-Diaz EB Binder, et al. 2008 Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-a and ribavirin treatment Mol Psychiatry 14 1095 1104 10.1038/mp.2008.48 18458677
38. MR Kraus O Al-Taie A Schefer, et al. 2007 Serotonin-1A receptor gene (HTR1A) vairation predicts interferon-induced depression chronic hepatitis C Gastroenterol 132 1279 1286 10.1053/j.gastro.2007.02.053 1:CAS:528: DC%2BD2sXlslKrur4%3D
39. AA Prather M Rabinovitz BG Pollock FE Lotrich 2009 Cytokine-induced depression during IFN-α treatment: the role of IL-6 and sleep quality Brain Behav Immun 23 1109 1116 10.1016/j.bbi.2009.07.001 1:CAS:528: DC%2BD1MXhtlGjurvP 19615438
40. L Capuron CL Raison DL Musselman, et al. 2003 Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy Am J Psychiatry 160 1342 1345 10.1176/appi.ajp.160.7.1342 12832253